Ultraviolette has raised an additional $39 million through an extension of its Series E funding round, with the EV manufacturer directing the capital at expanded electric-vehicle manufacturing capacity, according to a report carried by Dealroom.

The tranche extends an existing Series E round rather than opening a new financing chapter, though Dealroom did not state the cumulative Series E size or name the participating investors. Ultraviolette characterised the proceeds as infrastructure capital, not working capital.

What does the capital fund?

Ultraviolette states the funds will expand EV manufacturing. The announcement does not specify:

• Whether the expansion adds a second shift, a second line, or a second plant
• Annual unit-capacity additions
• Supplier localisation targets
• Battery and cell sourcing arrangements
• Headcount additions tied to the raise

For Series E-stage EV manufacturers, a raise of this size typically funds line additions, supplier tooling, and battery-pack assembly rather than greenfield plant construction. Ultraviolette has not confirmed which of those categories the new capital will support.

What remains undisclosed?

The Dealroom report carries the headline figure and the stated purpose. It does not include:

• Direct executive comments from the founder, CEO, or CFO
• Investor names or share allocations
• Post-money valuation
• Plant location, line count, or installed capacity
• Production-volume or shipment guidance

Trade-press coverage of EV manufacturer funding rounds usually leads with a founder or lead-investor quotation. The absence here means the announcement rests on the number alone, and the manufacturing footprint it will produce remains an announced intent rather than a confirmed capacity plan.

Where does this leave the Series E round?

Series E rounds at this stage usually coincide with a measurable production milestone — a capacity figure, a launch date, or a delivery target. Ultraviolette has not tied this tranche to any of those. Investors in prior rounds have included backers with interests in mobility and clean-energy infrastructure, though Dealroom did not identify participants in this extension.

The $39 million is a real, dated Series E tranche. The plant footprint, line additions, and unit output it will produce remain to be confirmed.

What to watch next

• Regulatory disclosure: whether Ultraviolette files with India's Ministry of Corporate Affairs naming the Series E participants and the post-money valuation.
• Production milestone: any quarterly shipment figure, dealer count, or capacity announcement that converts the $39 million from headline into delivered units.
• New programme timing: previously signalled follow-on EV programmes that would require expanded line capacity. Capital should appear in tooling orders or supplier contracts within two quarters if the expansion is active.
• Battery sourcing: cell-supplier disclosure or a captive pack-assembly announcement, since EV scale-up at this stage typically routes a meaningful share of capital into energy components.